Using Mice to Examine p53 Functions in Cancer, Aging, and Longevity
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
The p53 tumor suppressor is a multifaceted transcription factor that responds to a diverse array of stresses that include DNA damage and aberrant oncogene signaling. On activation, p53 prevents the emergence of cancer cells by initiating cell cycle arrest, senescence (terminal cell cycle arrest), or apoptosis. Although its role in assuring longevity by suppressing cancer is well established, recent studies obtained largely from genetically engineered mouse models suggest that p53 may regulate longevity and aging. In some contexts, it appears that altered p53 activity may enhance longevity, and in others, it appears to suppress longevity and accelerate aging phenotypes. Here, we discuss how genetically engineered mouse models have been used to explore antiproliferative functions of p53 in cancer suppression and how mouse models with altered aging phenotypes have shed light on how p53 might influence the aging process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 3×
“Overexpression of Ras in primary human or rodent cells results in senescence accompanied by p53 and p16 activation (Serrano et al. 1997).”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 5×
“High levels of phosphorylation of ATM, Chk2, and p53, indicating strong activation of the DNA damage response, were observed in precancerous lesions, but not normal tissues or fully malignant tumors (Bartkova et al. 2005; Gorgoulis et al. 2005).”
BackgroundInfluentialATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577 · cited 4×
“In addition, ATR and ATM activate the kinases Chk1 and Chk2, which phosphorylate p53 at serine 20 (Hirao et al. 2000; Abraham 2001; Shiloh 2003).”
BackgroundInfluentialSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 3×
“Subsequent studies by the Jacks and Lowe laboratories with inducible wild-type p53 mouse models showed that restoration of p53 function can cause dramatic tumor regression in part through induction of senescence (Ventura et al. 2007; Xue et al. 2007).”
BackgroundMethodSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 8×
“Many have hypothesized that tissue atrophy and functional decline are a result not only of increased cellular damage and genomic instability in mature somatic cells, but of failures in regenerative function in stem and progenitor cell compartments (Van Zant and Liang 2003; Chen 2004; Dumble et al. 2004; Pelicci 2004;…”
BackgroundInfluentialActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 5×
“Histopathological examination of tissues with preneoplastic lesions often shows an increase in fractions of apoptotic or senescent cells accompanying an elevated proliferation rate (Bartkova et al. 2005; Gorgoulis et al. 2005; Bartkova et al. 2006; Halazonetis et al. 2008).”
BackgroundInfluentialCell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 2×
“Subsequent studies by the Jacks and Lowe laboratories with inducible wild-type p53 mouse models showed that restoration of p53 function can cause dramatic tumor regression in part through induction of senescence (Ventura et al. 2007; Xue et al. 2007).”
BackgroundKruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · cited 2×
“Moreover, its stability is regulated by other molecules, such as Mdmx, Pirh2, Cop-1, HAUSP, ARF-BP1, and Pin1 (Brooks and Gu 2006; Kruse and Gu 2009).”
BackgroundSenescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 3×
“…in the lung and pancreas, early stage premalignant lung adenomas and pancreatic intraductal neoplasias showed high levels of several senescence markers, whereas malignant lung adenocarcinoma and pancreatic ductal adenocarcinomas displayed a comparative absence of such markers (Collado et al. 2005).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 5×
“However, the p53þ/m mice had a 23% shortened longevity compared with wild-type littermates and displayed a number of accelerated aging phenotypes, including organ atrophy, osteoporosis, skin atrophy, and reduced tolerance to stresses (Tyner et al. 2002).”
BackgroundInfluentialSelf-citationCloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 2×
“Cite this article as Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a001081 9 with reduced longevity and accelerated aging phenotypes (Rudolph et al. 1999).”
BackgroundInfluentialKinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106 · cited 2×
“Recent studies showing increases of the senescence effector p16INK4A protein levels and activity correlating with reduced function in aged stem and progenitor cells support this idea (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
BackgroundCytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106 · cited 3×
“Finally, p53 facilitates apoptosis directly and by nontranscriptional mechanisms through interaction with the multidomain members of the Bcl-2 family to induce mitochondrial outer membrane permeabilization and release of cytochrome c (Moll et al. 2005; Green and Kroemer 2009).”
BackgroundA Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
A role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046 · cited 1×
“One of the critical targets of the PIKKs is p53, which is phosphorylated directly at serines 15 and 37 (Canman et al. 1998; Tibbetts et al. 1999).”
BackgroundThe Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 2×
“Recent studies showing increases of the senescence effector p16INK4A protein levels and activity correlating with reduced function in aged stem and progenitor cells support this idea (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · cited 1×
“Crossing of these mice into a p53 null background resulted in a loss of the aging phenotypes associated with telomerase deficiency (Chin et al. 1999).”
Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972 · cited 2×
“Recent studies showing increases of the senescence effector p16INK4A protein levels and activity correlating with reduced function in aged stem and progenitor cells support this idea (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
BackgroundLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., & Van Dyke, T. (1994) · Cell · doi:10.1016/0092-8674(94)90534-7 · Cited by 880 · cited 1×
“In the first of such studies, mouse models with inactivated Rb in the eye and brain resulted in hyperproliferative lesions or weak tumors with high levels of apoptosis (Howes et al. 1994; Pan and Griep 1994; Symonds et al. 1994).”
BackgroundSenescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819 · cited 2×
“…sections revealed high levels of apoptosis, but if null alleles for p53 or p19ARF, the upstream regulator of p53, were introduced into the Em myc line, tumor incidence was greatly accelerated and evidence of apoptosis in the tumors was greatly diminished (Eischen et al. 1999; Schmitt et al. 1999).”
Backgroundp53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Nature · doi:10.1038/nature07443 · Cited by 767 · cited 1×
“Most recently, two studies have shown that p53 deficiency in hematopoietic multipotent progenitor cells and neural stem/progenitor cells contribute to enhanced proliferative capacity of these cells (Akala et al. 2008; Zheng et al. 2008).”
BackgroundInhibiting the p53–MDM2 interaction: an important target for cancer therapy
Chène, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc991 · Cited by 765
The retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738 · cited 2×
“This CDK suppression impacts on the retinoblastoma (Rb) gene pathway by maintaining Rb protein hypophosphorylation, which prevents E2F family members from initiating an S phase transcription program (Classon and Harlow 2002; Campisi 2005).”
BackgroundThe complexity of p53 stabilization and activation
Lavin, M. F., & Gueven, N. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401925 · Cited by 701 · cited 4×
“…results in p53 stabilization and facilitates its nuclear localization, where it acts as a potent transcriptional activator of a number of genes involved in an array of cellular functions, including DNA repair, apoptosis, and cell cycle regulation (Levine 1997; Vousden 2002; Lavin and Gueven 2006).”
BackgroundInfluentialStem cells, ageing and the quest for immortality
Rando, T. A. (2006) · Nature · doi:10.1038/nature04958 · Cited by 695
Parrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631 · cited 1×
“Moreover, senescent cells could disrupt normal epithelial cell functions and differentiation (Parrinello et al. 2005).”
BackgroundModeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600 · cited 5×
“The lymphoma regression was accompanied by massive tumor cell apoptosis (Martins et al. 2006).”
BackgroundMethodInfluentialModulation of mammalian life span by the short isoform of p53
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586 · cited 4×
“The mechanism of these early aging phenotypes was ascribed by the authors, at least in part, to hyperactivation of the IGF-1 signaling axis (Maier et al. 2004).”
BackgroundInfluentialPendás, A. M., Zhou, Z., Cadiñanos, J., Freije, J. M. P., Wang, J., Hultenby, K., Astudillo, A., Wernerson, A., Rodríguez, F., Tryggvason, K., et al. (2002) · Nature Genetics · doi:10.1038/ng871 · Cited by 554
DNA repair is limiting for haematopoietic stem cells during ageing
Nijnik, A., Woodbine, L., Marchetti, C., Dawson, S., Lambe, T., Liu, C., Rodrigues, N. P., Crockford, T. L., Cabuy, E., Vindigni, A., et al. (2007) · Nature · doi:10.1038/nature05875 · Cited by 518
Cancer and ageing: rival demons?
Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512 · cited 1×
“Cancer rates increase dramatically with age in both humans and mice (Balducci and Beghe 2001; Campisi 2003).”
BackgroundTelomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice
Tomás-Loba, A., Flores, I., Fernández-Marcos, P. J., Cayuela, M. L., Maraver, A., Tejera, A., Borrás, C., Matheu, A., Klatt, P., Flores, J. M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.034 · Cited by 484 · cited 2×
“The super p53 mice have been further augmented by the generation of telomerase reverse transcriptase (TERT) overexpressing alleles in the background of overexpressed p53, p16INK4a, and p19ARF (Tomas-Loba et al. 2008).”
BackgroundTranscription-independent pro-apoptotic functions of p53
Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468
Delayed ageing through damage protection by the Arf/p53 pathway
Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Viña, J., Blasco, M. A., & Serrano, M. (2007) · Nature · doi:10.1038/nature05949 · Cited by 466 · cited 5×
“On the other hand, the improved aging parameters in the super p53/ ARF mice suggest that the possibility that stem cell functionality is somehow maintained at more optimal levels in the presence of a more robust ARF-p53 pathway (Matheu et al. 2007).”
BackgroundInfluentialAccelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation
Varela, I., Cadiñanos, J., Pendás, A. M., Gutiérrez-Fernández, A., Folgueras, A. R., Sánchez, L. M., Zhou, Z., Rodríguez, F. J., Stewart, C. L., Vega, J. A., et al. (2005) · Nature · doi:10.1038/nature04019 · Cited by 466 · cited 3×
“In addition, the accelerated aging phenotypes and reduced life span of the Zmpste24 null mice were partially rescued by the absence of p53 (Varela et al. 2005), indicating that activated p53 was likely responsible for some of the progeroid phenotypes. p53 Mutant Mice with Altered Aging and…”
BackgroundInfluentialINK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R., & Lowe, S. W. (1999) · Genes & Development · doi:10.1101/gad.13.20.2670 · Cited by 458 · cited 2×
“…sections revealed high levels of apoptosis, but if null alleles for p53 or p19ARF, the upstream regulator of p53, were introduced into the Em myc line, tumor incidence was greatly accelerated and evidence of apoptosis in the tumors was greatly diminished (Eischen et al. 1999; Schmitt et al. 1999).”
BackgroundThe pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Nature · doi:10.1038/nature05077 · Cited by 382
DNA damage and ageing: new-age ideas for an age-old problem
Garinis, G. A., van der Horst, G. T. J., Vijg, J., & H.J. Hoeijmakers, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1108-1241 · Cited by 366 · cited 2×
“It is well established that mammalian cells incur various types of damage with age, and the damage itself or the cellular damage responses could both contribute to aging phenotypes (Garinis et al. 2008; Maslov and Vijg 2009).”
BackgroundCao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C.-X. (2003) · Genes & Development · doi:10.1101/gad.1050003 · Cited by 293 · cited 2×
“The Brca1D11/D11 mice die during embryogenesis but Brca1D11/D11 p53þ/2 females survive and develop mammary tumors, whereas the males showed evidence of accelerated aging phenotypes (Cao et al. 2003).”
BackgroundFeng, Z., Hu, W., Teresky, A. K., Hernando, E., Cordon-Cardo, C., & Levine, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708043104 · Cited by 264
Cancer and ageing: a nexus at several levels
Balducci, L., & Ershler, W. B. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1675 · Cited by 250
Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228
Role of p14ARF in Replicative and Induced Senescence of Human Fibroblasts
Wei, W., Hemmer, R. M., & Sedivy, J. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6748-6757.2001 · Cited by 217 · cited 1×
“In this situation, the senescence response can actually be reversed, and cells can re-enter the cell cycle (Brown et al. 1997; Wei et al. 2001; Rodier et al. 2007).”
BackgroundTumor suppression and normal aging in mice with constitutively high p53 activity
Mendrysa, S. M., O'Leary, K. A., McElwee, M. K., Michalowski, J., Eisenman, R. N., Powell, D. A., & Perry, M. E. (2006) · Genes & Development · doi:10.1101/gad.1378506 · Cited by 210 · cited 3×
“Similarly, another mouse model, generated by Perry and collaborators, was hypomorphic for Mdm2 activity (Mendrysa et al. 2006).”
BackgroundCancer and ageing: convergent and divergent mechanisms
Serrano, M., & Blasco, M. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2242 · Cited by 182
Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice
Sluss, H. K., Armata, H., Gallant, J., & Jones, S. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.976-984.2004 · Cited by 152 · cited 2×
“Such phosphorylation events are important for p53 functional activation, as defects in phosphorylation at these sites decrease p53 transcriptional functions (Appella and Anderson 2001; Sluss et al. 2004).”
BackgroundSenescence and functional failure in hematopoietic stem cells
Chen, J. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.08.001 · Cited by 53 · cited 4×
“…and progenitor cell compartments because of age-associated reductions in self-renewal, proliferation, and differentiation (Van Zant and Liang 2003; Chen 2004; Dumble et al. 2004; Pelicci 2004; Sharpless and DePinho 2004; Campisi 2005; Rando 2006; Rodier et al. 2007; Sharpless and DePinho 2007;…”
BackgroundInfluentialCooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis
Moore, L., Venkatachalam, S., Vogel, H., Watt, J. C., Wu, C.-L., Steinman, H., Jones, S. N., & Donehower, L. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206985 · Cited by 48 · cited 2×
“In experiments performed in my laboratory, mice that completely lack Arf and p53 genes have a tumor incidence similar to that of p53-null mice, suggesting that tumor suppression by ARF proceeds completely through p53 (Moore et al. 2003).”
BackgroundSelf-citation
Cited by
AMP-Activated Protein Kinase (AMPK) Controls the Aging Process via an Integrated Signaling Network
Salminen, A., & Kaarniranta, K. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.005 · Cited by 860
The ageing haematopoietic stem cell compartment
Geiger, H., de Haan, G., & Florian, M. C. (2013) · Nature Reviews Immunology · doi:10.1038/nri3433 · Cited by 604
p53 Research: The Past Thirty Years and the Next Thirty Years
Lane, D., & Levine, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000893 · Cited by 454
Maddocks, O. D. K., & Vousden, K. H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0735-5 · Cited by 355
Silvis, M. R., Kreger, B. T., Lien, W.-H., Klezovitch, O., Rudakova, G. M., Camargo, F. D., Lantz, D. M., Seykora, J. T., & Vasioukhin, V. (2011) · Science Signaling · doi:10.1126/scisignal.2001823 · Cited by 342
Metadata
- Authors
- Donehower, L. A.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2009-11-04
- Volume
- 1
- Issue
- 6
- Pages
- a001081-a001081
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2119739394
- Cited by
- 55
- References
- 58
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.